A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer’s Disease
暂无分享,去创建一个
[1] S. M. de la Monte,et al. Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.
[2] Christina Kendziorski,et al. R/EBcoexpress: an empirical Bayesian framework for discovering differential co-expression , 2012, Bioinform..
[3] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[4] G. Pawelec,et al. Immune profiling of Alzheimer patients , 2012, Journal of Neuroimmunology.
[5] C. Lyketsos,et al. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease , 2013, International journal of geriatric psychiatry.
[6] Eric M Reiman,et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. , 2007, Physiological genomics.
[7] Chao Wu,et al. Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes , 2012, BMC Bioinformatics.
[8] Yingying Jia,et al. Meta-Analysis of Ubiquilin1 Gene Polymorphism and Alzheimer’s Disease Risk , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[9] Peter Schönknecht,et al. Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany. , 2009, Journal of Alzheimer's disease : JAD.
[10] Zhichun Chen,et al. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies , 2013, Progress in Neurobiology.
[11] W. Markesbery,et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Orengo,et al. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma , 2006, BMC Genomics.
[13] Michael S. McGrath,et al. Systemic immune system alterations in early stages of Alzheimer's disease , 2013, Journal of Neuroimmunology.
[14] M. Barbagallo,et al. Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. , 2010, Journal of Alzheimer's disease : JAD.
[15] J. Bao,et al. Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[16] Melanie J. Lucero,et al. Running reduces stress and enhances cell genesis in aged mice , 2011, Neurobiology of Aging.
[17] Yun-xia Yu,et al. Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[18] Eric M. Blalock,et al. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.
[19] G. Kemmler,et al. Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects , 2011, Dementia and Geriatric Cognitive Disorders Extra.
[20] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[21] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[22] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[23] Yuren Jiang,et al. Butyrylcholinesterase K Variant and Alzheimer’s Disease Risk: A Meta-Analysis , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[24] Winnie S. Liang,et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.
[25] Jaesung Lee,et al. Efficient multivariate feature filter using conditional mutual information , 2012 .
[26] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[27] E. McAuley,et al. Aerobic fitness is associated with hippocampal volume in elderly humans , 2009, Hippocampus.
[28] Roger N Rosenberg,et al. Genome-wide association studies in Alzheimer disease. , 2008, Archives of neurology.
[29] Richard Mayeux,et al. Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.
[30] J. Morillas-Ruiz,et al. A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.
[31] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[32] S. Jo,et al. Identification of peripheral inflammatory markers between normal control and Alzheimer's disease , 2011, BMC neurology.
[33] John D. Minna,et al. Probe mapping across multiple microarray platforms , 2012, Briefings Bioinform..
[34] T. Wisniewski,et al. The Innate Immune System in Alzheimer's Disease , 2013, International journal of cell biology.
[35] L. Beckett,et al. Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.
[36] E Skafidas,et al. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis , 2012, Molecular Psychiatry.
[37] Dimitrios Kapogiannis,et al. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.
[38] Hugues Bersini,et al. Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages , 2012, BMC Bioinformatics.
[39] Christina Kendziorski,et al. An Empirical Bayesian Approach for Identifying Differential Coexpression in High‐Throughput Experiments , 2012, Biometrics.
[40] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[41] Steven C. Lawlor,et al. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data , 2003, Genome Biology.
[42] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[43] Ronald C. Petersen,et al. Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics , 2013, PloS one.
[44] Adrian E. Raftery,et al. Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .
[45] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[46] L. Tan,et al. Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease , 2012, Journal of the Neurological Sciences.